Named on one round in the feed.
Since 2026-11-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Nanopath A point-of-care diagnostics company enabling laboratory-quality molecular testing in minutes | Series B Verified against 4 of 5 sources | $25M | 2026-11-10 | [ LEAD ] |